vs
NEOGENOMICS INC（NEO）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是NEOGENOMICS INC的1.7倍（$324.4M vs $186.7M），Revolve Group, Inc.净利率更高（5.7% vs -57.9%，领先63.6%），NEOGENOMICS INC同比增速更快（11.1% vs 10.4%），过去两年Revolve Group, Inc.的营收复合增速更高（9.5% vs 6.5%）
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
NEO vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.7倍
$186.7M
营收增速更快
NEO
高出0.7%
10.4%
净利率更高
RVLV
高出63.6%
-57.9%
两年增速更快
RVLV
近两年复合增速
6.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $186.7M | $324.4M |
| 净利润 | $-108.0M | $18.6M |
| 毛利率 | 43.3% | 53.3% |
| 营业利润率 | — | 6.3% |
| 净利率 | -57.9% | 5.7% |
| 营收同比 | 11.1% | 10.4% |
| 净利润同比 | 42.0% | 50.4% |
| 每股收益（稀释后） | $-0.13 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEORVLV
| Q1 26 | $186.7M | — | ||
| Q4 25 | $190.2M | $324.4M | ||
| Q3 25 | $187.8M | $295.6M | ||
| Q2 25 | $181.3M | $309.0M | ||
| Q1 25 | $168.0M | $296.7M | ||
| Q4 24 | $172.0M | $293.7M | ||
| Q3 24 | $167.8M | $283.1M | ||
| Q2 24 | $164.5M | $282.5M |
净利润NEORVLV
| Q1 26 | $-108.0M | — | ||
| Q4 25 | — | $18.6M | ||
| Q3 25 | $-27.1M | $21.2M | ||
| Q2 25 | $-45.1M | $10.2M | ||
| Q1 25 | $-25.9M | $11.8M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | $-17.7M | $11.0M | ||
| Q2 24 | $-18.6M | $15.4M |
毛利率NEORVLV
| Q1 26 | 43.3% | — | ||
| Q4 25 | 43.8% | 53.3% | ||
| Q3 25 | 42.8% | 54.6% | ||
| Q2 25 | 42.6% | 54.1% | ||
| Q1 25 | 43.6% | 52.0% | ||
| Q4 24 | 44.9% | 52.5% | ||
| Q3 24 | 44.6% | 51.2% | ||
| Q2 24 | 44.1% | 54.0% |
营业利润率NEORVLV
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | 6.3% | ||
| Q3 25 | -14.4% | 7.1% | ||
| Q2 25 | -26.3% | 5.8% | ||
| Q1 25 | -16.6% | 5.0% | ||
| Q4 24 | -10.7% | 3.9% | ||
| Q3 24 | -12.6% | 5.0% | ||
| Q2 24 | -13.3% | 5.8% |
净利率NEORVLV
| Q1 26 | -57.9% | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | -14.4% | 7.2% | ||
| Q2 25 | -24.9% | 3.3% | ||
| Q1 25 | -15.4% | 4.0% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | -10.5% | 3.9% | ||
| Q2 24 | -11.3% | 5.4% |
每股收益（稀释后）NEORVLV
| Q1 26 | $-0.13 | — | ||
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.29 | ||
| Q2 25 | — | $0.14 | ||
| Q1 25 | — | $0.16 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | — | $0.15 | ||
| Q2 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.1M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $828.8M | $512.5M |
| 总资产 | $1.3B | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEORVLV
| Q1 26 | $146.1M | — | ||
| Q4 25 | $159.6M | $292.3M | ||
| Q3 25 | $164.1M | $315.4M | ||
| Q2 25 | $154.7M | $310.7M | ||
| Q1 25 | $346.2M | $300.8M | ||
| Q4 24 | $367.0M | $256.6M | ||
| Q3 24 | $362.0M | $252.8M | ||
| Q2 24 | $355.1M | $244.7M |
总债务NEORVLV
| Q1 26 | — | — | ||
| Q4 25 | $341.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $541.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NEORVLV
| Q1 26 | $828.8M | — | ||
| Q4 25 | $836.6M | $512.5M | ||
| Q3 25 | $838.3M | $490.2M | ||
| Q2 25 | $854.0M | $468.6M | ||
| Q1 25 | $888.3M | $453.4M | ||
| Q4 24 | $902.3M | $437.8M | ||
| Q3 24 | $908.2M | $420.8M | ||
| Q2 24 | $915.9M | $405.8M |
总资产NEORVLV
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.4B | $765.0M | ||
| Q3 25 | $1.4B | $751.3M | ||
| Q2 25 | $1.4B | $722.9M | ||
| Q1 25 | $1.6B | $713.9M | ||
| Q4 24 | $1.6B | $665.5M | ||
| Q3 24 | $1.6B | $670.9M | ||
| Q2 24 | $1.6B | $657.8M |
负债/权益比NEORVLV
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.1M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-13.3M |
| 自由现金流率自由现金流/营收 | — | -4.1% |
| 资本支出强度资本支出/营收 | — | 1.0% |
| 现金转化率经营现金流/净利润 | — | -0.55× |
| 过去12个月自由现金流最近4个季度 | — | $48.0M |
8季度趋势，按日历期对齐
经营现金流NEORVLV
| Q1 26 | $-8.1M | — | ||
| Q4 25 | $1.3M | $-10.2M | ||
| Q3 25 | $8.9M | $11.8M | ||
| Q2 25 | $20.3M | $12.6M | ||
| Q1 25 | $-25.3M | $45.1M | ||
| Q4 24 | $9.8M | $3.9M | ||
| Q3 24 | $9.2M | $9.1M | ||
| Q2 24 | $13.9M | $-24.7M |
自由现金流NEORVLV
| Q1 26 | — | — | ||
| Q4 25 | $-6.5M | $-13.3M | ||
| Q3 25 | $570.0K | $7.5M | ||
| Q2 25 | $14.0M | $10.4M | ||
| Q1 25 | $-29.8M | $43.4M | ||
| Q4 24 | $-1.8M | $2.1M | ||
| Q3 24 | $-1.6M | $8.0M | ||
| Q2 24 | $814.0K | $-25.7M |
自由现金流率NEORVLV
| Q1 26 | — | — | ||
| Q4 25 | -3.4% | -4.1% | ||
| Q3 25 | 0.3% | 2.5% | ||
| Q2 25 | 7.7% | 3.4% | ||
| Q1 25 | -17.8% | 14.6% | ||
| Q4 24 | -1.0% | 0.7% | ||
| Q3 24 | -0.9% | 2.8% | ||
| Q2 24 | 0.5% | -9.1% |
资本支出强度NEORVLV
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 1.0% | ||
| Q3 25 | 4.4% | 1.5% | ||
| Q2 25 | 3.5% | 0.7% | ||
| Q1 25 | 2.7% | 0.6% | ||
| Q4 24 | 6.7% | 0.6% | ||
| Q3 24 | 6.4% | 0.4% | ||
| Q2 24 | 8.0% | 0.4% |
现金转化率NEORVLV
| Q1 26 | — | — | ||
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEO
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
